文献速递心脑血管急症重症综合管理与镇静镇痛

基于通用数据模型的癫痫持续状态严重程度与病因相关临床结局及全身并发症

Clinical Outcomes and Systemic Complications Related to the Severity and Etiology of Status Epilepticus Using a Common Data Model.
PubMed 文献 · Neurocrit Care · 2023-12-07
一句话结论癫痫持续状态严重程度越高住院与ICU时间越长,住院死亡组肾功能障碍和血小板减少更常见,多因素分析中APACHE II评分与血小板计数与住院死亡独立相关。

该回顾性队列研究基于单一三级学术医学中心的通用数据模型数据库,纳入2001年1月1日至2018年1月1日诊断为癫痫持续状态(ICD-10编码G41且接受抗癫痫药物治疗)的410例患者。非难治性癫痫持续状态占65.4%(268/410),难治性占28.5%(117/410),超级难治性占6.1%(25/410);癫痫持续状态越严重,ICU和住院时间越长。住院死亡组肾功能障碍(P=0.002)和血小板减少(P=0.003)比例更高;多因素分析中APACHE II评分(OR 1.169,P=0.004)和血小板计数(OR 0.989,P=0.043)在住院死亡组有显著差异。作者认为癫痫持续状态后全身并发症,尤其是低血小板计数,与更差结局和死亡率增加相关;通用数据模型具有可扩展性和综合分析能力,可能成为癫痫持续状态研究的有价值工具。

要点

  • 癫痫持续状态严重程度越高,ICU和住院时间越长:非难治性占65.4%(268/410)、难治性占28.5%(117/410)、超级难治性占6.1%(25/410)。
  • 住院死亡组肾功能障碍和血小板减少比例更高(P=0.002和P=0.003)。
  • 多因素分析中APACHE II评分与住院死亡显著相关(OR 1.169,P=0.004),血小板计数与住院死亡显著相关(OR 0.989,P=0.043)。
  • 作者认为癫痫持续状态后全身并发症,尤其低血小板计数,与更差结局和死亡率增加相关。
  • 作者认为通用数据模型具有可扩展性和综合分析能力,可能成为癫痫持续状态研究的有价值工具。

适用人群与场景

  • 单一三级学术医学中心通用数据模型数据库中2001年1月1日至2018年1月1日诊断为癫痫持续状态(ICD-10编码G41且接受抗癫痫药物治疗)的患者,共410例。

诊断标准与关键阈值

  • 癫痫持续状态诊断依据:ICD-10编码G41且接受抗癫痫药物治疗。
  • 全身并发症依据序贯器官衰竭评估(SOFA)标准定义。

研究设计与关键结果

  • 回顾性队列研究,基于单一三级学术医学中心通用数据模型数据库,1,825,196例患者的电子病历转化为通用数据模型,最终纳入410例癫痫持续状态患者。
  • 癫痫持续状态严重程度分布:非难治性65.4%(268/410),难治性28.5%(117/410),超级难治性6.1%(25/410)。
  • 癫痫持续状态越严重,ICU和住院时间越长。
  • 住院死亡组肾功能障碍比例高于非死亡组(P=0.002),血小板减少比例高于非死亡组(P=0.003)。
  • 多因素分析中,住院死亡组APACHE II评分显著不同(OR 1.169,P=0.004),血小板计数显著不同(OR 0.989,P=0.043)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为癫痫持续状态后全身并发症,尤其是低血小板计数,与更差结局和死亡率增加相关。
  • 作者认为通用数据模型具有可扩展性和综合分析能力,可能成为癫痫持续状态研究的有价值工具。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Status epilepticus (SE) is a critical neurological emergency in patients with neurological and nonneurological diseases. Mortality rises with SE severity. However, whether brain injury or systemic organ dysfunction causes death after SE remains unclear. We studied clinical outcomes and systemic dysfunctions associated with SE using standardized data from the common data model. This model includes clinical evaluations and treatments that provide real-world evidence for standard practice.

METHODS: This retrospective cohort study used the common data model database of a single tertiary academic medical center. Patients diagnosed with SE (corresponding to G41 of the International Classification of Diseases 10 and administration of antiseizure medication) between January 1, 2001, and January 1, 2018, were enrolled. Demographics, classifications of SE severity, and outcomes were collected as operational definitions by using a common data model format. Systemic complications were defined based on the Sequential Organ Failure Assessment criteria.

RESULTS: The electronic medical records of 1,825,196 patients were transformed into a common data model, and 410 patients were enrolled. The proportion of patients classified as having nonrefractory SE was 65.4% (268/410), followed by refractory (28.5%, 117/410) and super-refractory SE (6.1%, 25/410). Patients with more severe SE had longer intensive care unit and hospital stays. Renal dysfunction and thrombocytopenia were higher in the in-hospital death group (P = 0.002 and 0.003, respectively). In multivariable analysis, the Acute Physiology and Chronic Health Evaluation II score and platelet count were significantly different in the in-hospital death group (odds ratio, 1.169, P = 0.004; and 0.989, P = 0.043).

CONCLUSIONS: Systemic complications after SE, especially low platelet counts, were linked to worse outcomes and increased mortality in a common data model. The common data model offers expandability and comprehensive analysis, making it a potentially valuable tool for SE research.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Park J, Kim MH, Lee HW, et al. Clinical Outcomes and Systemic Complications Related to the Severity and Etiology of Status Epilepticus Using a Common Data Model. Neurocrit Care. 2023. PMID: 38062300. doi:10.1007/s12028-023-01889-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。